Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
18 results
D1.134 - Mapping the Patient’s Journey Prior to Allergen Immunotherapy
D1.135 - ”Bee Pollen” as a Potential Trigger for Anaphylaxis: A Case Study
D1.137 - Characterization of Pana g 1, a novel allergen from Korean ginseng, Panax ginseng triggering Pollen-Food Allergy Syndrome
D1.138 - IgE cross-reactivity between grass species in the presence of Japanese cedar pollen sensitization
D1.139 - Staphylococcus aureus (carriage and sensitization) - is it a significant factor in allergic rhinitis?
D1.144 - Global variations of IgE cross-reactivity in Cupressus allergy
D1.145 - A Clinical Decision Support System (CDSS) based on Machine Learning for the diagnosis of Seasonal Allergenic Rhinitis (SAR) and patient-tailored AIT prescription
D1.148 - Heterogeneity of sensitization profiles between Central and Southern European allergic patients
D2.168 - Systemic reactions to subcutaneous immunotherapy in children
D2.170 - The placebo effect leads to significantly lower values regarding allergic symptoms and medication use in birch-pollen allergic patients during the birch pollen season
D2.171 - The individual benefit of subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is already evident in the first season immediately after treatment
D2.172 - Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions
D2.173 - Subcutaneous allergen-specific immunotherapies for inhalation allergens induce higher levels of therapy specific IgG4 antibodies than sublingual therapies: a retrospective data analysis
D2.175 - TAPAS – non-inferiority of clinical effectiveness in children compared to adults: interim results of a long-term NIS
D2.176 - Improved quality of life after PQ Grass in comparison to SLIT products in grass allergic patients
D2.177 - The Efficacy of Sublingual Immunotherapy in Mild versus Moderate Atopic Dermatitis Among Children with House Dust Mite Allergic Rhinitis
D2.178 - Allergen-specific IgE/IgG4 ratio as biomarker of allergen immunotherapy efficacy in house dust mite-sensitized allergic rhinitis
D2.180 - Immunological evaluation of cat allergic individuals living with or without a cat
Download the app
The congress at your fingertips
Available on
Download